Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 401 Records) |
| Query Trace: Neoplasms and ESR1[original query] |
|---|
| Genomic Landscape of Circulating-Tumor DNA in a Diverse Cohort of Metastatic Breast Cancer Patients. Oncology research and treatment 2022 12 46 (1-2): 26-32. Cheng Shirley, Nguyen Edward Tri, Pagano Ian, Fukui Jami A |
| Circulating tumor DNA profile and its clinical significance in patients with hormone receptor-positive and HER2-negative mBC. Frontiers in endocrinology 2022 12 13 1075830. Tang Yu, Li Jing, Liu Binliang, Ran Jialu, Hu Zhe-Yu, Ouyang Qucha |
| Molecular differences between younger versus older ER-positive and HER2-negative breast cancers. NPJ breast cancer 2022 11 8 (1): 119. Qing Tao, Karn Thomas, Rozenblit Mariya, Foldi Julia, Marczyk Michal, Shan Naing Lin, Blenman Kim, Holtrich Uwe, Kalinsky Kevin, Meric-Bernstam Funda, Pusztai Laj |
| The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR?+?/HER2?-) advanced/metastatic breast cancer. Breast cancer research and treatment 2022 11 197 (2): 319-331. Bardia Aditya, Mayer Ingrid, Winer Eric, Linden Hannah M, Ma Cynthia X, Parker Barbara A, Bellet Meritxell, Arteaga Carlos L, Cheeti Sravanthi, Gates Mary, Chang Ching-Wei, Fredrickson Jill, Spoerke Jill M, Moore Heather M, Giltnane Jennifer, Friedman Lori S, Chow Maneval Edna, Chan Iris, Jhaveri Kom |
| Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial. The Lancet. Oncology 2022 10 23 (11): 1367-1377. Bidard François-Clément, Hardy-Bessard Anne-Claire, Dalenc Florence, Bachelot Thomas, Pierga Jean-Yves, de la Motte Rouge Thibault, Sabatier Renaud, Dubot Coraline, Frenel Jean-Sébastien, Ferrero Jean Marc, Ladoire Sylvain, Levy Christelle, Mouret-Reynier Marie-Ange, Lortholary Alain, Grenier Julien, Chakiba Camille, Stefani Laetitia, Plaza Jérôme Edouard, Clatot Florian, Teixeira Luis, D'Hondt Véronique, Vegas Hélène, Derbel Olfa, Garnier-Tixidre Claire, Canon Jean-Luc, Pistilli Barbara, André Fabrice, Arnould Laurent, Pradines Anne, Bièche Ivan, Callens Céline, Lemonnier Jérôme, Berger Frédérique, Delaloge Suzette, |
| Unique ESR1 and ESR2 estrogen receptor gene variants associated with altered risk of triple-negative breast cancer: A case-control study. Gene 2022 Oct 851 146969. Sghaier Ikram, Zidi Sabrina, El-Ghali Rabeb M, Daldoul Amira, Aimagambetova Gulzhanat, Almawi Wassim |
| Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor-Positive Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 10 28 (23): 5066-5078. Tsuji Junko, Li Tianyu, Grinshpun Albert, Coorens Tim, Russo Douglas, Anderson Leilani, Rees Rebecca, Nardone Agostina, Patterson Candace, Lennon Niall J, Cibulskis Carrie, Leshchiner Ignaty, Tayob Nabihah, Tolaney Sara M, Tung Nadine, McDonnell Donald P, Krop Ian E, Winer Eric P, Stewart Chip, Getz Gad, Jeselsohn Rina |
| Validation of liquid biopsy for ESR1-mutation analysis in hormone-sensitive breast cancer: a pooled meta-analysis. Frontiers in oncology 2023 9 13 1221773. Omar Najim, Konstantinos Papadimitriou, Glenn Broeckx, Manon Huizing, Wiebren Tjal |
| Frequency of genetic alterations differs in advanced breast cancer between metastatic sites. Genes, chromosomes & cancer 2023 9 . Isabel Grote, Alexandra Poppe, Ulrich Lehmann, Matthias Christgen, Hans Kreipe, Stephan Barte |
| Single Nucleotide Polymorphisms Associated with Female Breast cancer Susceptibility in Chinese Population. Gene 2023 7 147676. Ziqi Jia, Yansong Huang, Jiaqi Liu, Gang Liu, Jiayi Li, Hengyi Xu, Yiwen Jiang, Song Zhang, Yidan Wang, Gang Chen, Guangdong Qiao, Yalun |
| FOXK2 amplification and overexpression promotes breast cancer development and chemoresistance. bioRxiv : the preprint server for biology 2023 7 . Yang Yu, Wen-Ming Cao, Feng Cheng, Zhongcheng Shi, Lili Han, Jin-Ling Yi, Edaise M da Silva, Higinio Dopeso, Hui Chen, Jianhua Yang, Xiaosong Wang, Chunchao Zhang, Hong Zha |
| Real-World Use of Highly Sensitive Liquid Biopsy Monitoring in Metastatic Breast Cancer Patients Treated with Endocrine Agents after Exposure to Aromatase Inhibitors. International journal of molecular sciences 2023 7 24 (14): . Jesús Fuentes-Antrás, Ana Martínez-Rodríguez, Kissy Guevara-Hoyer, Igor López-Cade, Víctor Lorca, Alejandro Pascual, Alicia de Luna, Carmen Ramírez-Ruda, Jennifer Swindell, Paloma Flores, Ana Lluch, David W Cescon, Pedro Pérez-Segura, Alberto Ocaña, Frederick Jones, Fernando Moreno, Vanesa García-Barberán, José Ángel García-Sáe |
| Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer. Genome medicine 2023 7 15 (1): 55. Yeon Hee Park, Seock-Ah Im, Kyunghee Park, Ji Wen, Kyung-Hun Lee, Yoon-La Choi, Won-Chul Lee, Ahrum Min, Vinicius Bonato, Seri Park, Sripad Ram, Dae-Won Lee, Ji-Yeon Kim, Su Kyeong Lee, Won-Woo Lee, Jisook Lee, Miso Kim, Hyun Seon Kim, Scott L Weinrich, Han Suk Ryu, Tae Yong Kim, Stephen Dann, Yu-Jin Kim, Diane R Fernandez, Jiwon Koh, Shuoguo Wang, Song Yi Park, Shibing Deng, Eric Powell, Rupesh Kanchi Ravi, Jadwiga Bienkowska, Paul A Rejto, Woong-Yang Park, Zhengyan K |
| Clinical and Genomic Characteristics of Patients with HR+, HER2- Metastatic Breast Cancer Following Progression on a CDK4 and 6 Inhibitor. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 6 . Xi Rao, Yongmei Chen, Julie Beyrer, Emily Nash Smyth, Claudia Morato Guimaraes, Lacey M Litchfield, Lee Bowman, Garreth W Lawrence, Amit Aggarwal, Fabrice And |
| Alternating 17?-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 6 OF1-OF7. Gary N Schwartz, Peter A Kaufman, Karthik V Giridhar, Jonathan D Marotti, Mary D Chamberlin, Bradley A Arrick, Grace Makari-Judson, Matthew P Goetz, Shannon M Soucy, Fred Kolling, Eugene Demidenko, Todd W Mill |
| Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker Analysis. JCO precision oncology 2023 5 7 e2200531. Lorenzo Gerratana, Andrew A Davis, Marko Velimirovic, Carolina Reduzzi, Katherine Clifton, Leslie Bucheit, Whitney L Hensing, Ami N Shah, Tania Pivetta, Charles S Dai, Paolo D'Amico, Firas Wehbe, Arielle Medford, Seth A Wander, William J Gradishar, Amir Behdad, Cynthia X Ma, Fabio Puglisi, Aditya Bardia, Massimo Cristofanil |
| Plasma ESR1 mutations and outcome to first-line paclitaxel and bevacizumab in patients with advanced ER-positive/HER2-negative breast cancer. Breast cancer research and treatment 2023 5 . M K Bos, S W Lam, G Motta, J C A Helmijr, C M Beaufort, E de Jonge, J W M Martens, E Boven, M P H M Jansen, A Jager, S Sleijf |
| Detection of Ultra-Rare ESR1 Mutations in Primary Breast Cancer Using LNA-Clamp ddPCR. Cancers 2023 5 15 (9): . Yoko Hashimoto, Nanae Masunaga, Naofumi Kagara, Kaori Abe, Tetsuhiro Yoshinami, Masami Tsukabe, Yoshiaki Sota, Tomohiro Miyake, Tomonori Tanei, Masafumi Shimoda, Kenzo Shima |
| Design of SERENA-6, a phase III switching trial of camizestrant in ESR1-mutant breast cancer during first-line treatment. Future oncology (London, England) 2023 4 . Nicholas Turner, Cynthia Huang-Bartlett, Kevin Kalinsky, Massimo Cristofanilli, Giampaolo Bianchini, Stephen Chia, Hiroji Iwata, Wolfgang Janni, Cynthia X Ma, Erica L Mayer, Yeon Hee Park, Steven Fox, Xiaochun Liu, Sasha McClain, Francois-Clement Bida |
| Exceptional responses to PARP inhibitors in patients with metastatic breast cancer in oncologic crisis. Breast cancer research and treatment 2023 3 1-9. Cheng Joyce M, Canzoniero Jenna, Lee Seoho, Soni Sudeep, Mangini Neha, Santa-Maria Cesar |
| DNA methylation age in paired tumor and adjacent normal breast tissue in Chinese women with breast cancer. Clinical epigenetics 2023 3 15 (1): 55. Koka Hela, Bodelon Clara, Horvath Steve, Lee Priscilla Ming Yi, Wang Difei, Song Lei, Zhang Tongwu, Hurson Amber N, Guida Jennifer Lyn, Zhu Bin, Bailey-Whyte Maeve, Wang Feng, Wu Cherry, Tsang Koon Ho, Tsoi Yee-Kei, Chan W C, Law Sze Hong, Hung Ray Ka Wai, Tse Gary M, Yuen Karen Ka-Wan, Karlins Eric, Jones Kristine, Vogt Aurelie, Zhu Bin, Hutchinson Amy, Hicks Belynda, Garcia-Closas Montserrat, Chanock Stephen, Barnholtz-Sloan Jill, Tse Lap Ah, Yang Xiaohong |
| HR/HER2 de novo metastatic breast cancer: a true peculiar entity? Drugs in context 2023 3 12 . Torrisi Rosalba, Jacobs Flavia, Miggiano Chiara, De Sanctis Rita, Santoro Arman |
| Clinical efficacy of fulvestrant versus exemestane as first-line therapies for Chinese postmenopausal oestrogen-receptor positive /human epidermal growth factor receptor 2 -advanced breast cancer (FRIEND study). European journal of cancer (Oxford, England : 1990) 2023 3 184 73-82. Wang Jiayu, Cai Li, Song Yanqiu, Sun Tao, Tong Zhongsheng, Teng Yuee, Li Huiping, Ouyang Quchang, Chen Qianjun, Cui Shude, Yin Yongmei, Liao Ning, Sun Qiang, Feng Jifeng, Wang Xiaojia, Xu Bing |
| Clinical relevance of circulating ESR1 mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma. BMC cancer 2023 11 23 (1): 1061. Aurélien Drouyer, Ludivine Beaussire, Pauline Jorda, Marianne Leheurteur, Cécile Guillemet, Anca Berghian, Dragos Georgescu, Frédéric Di Fiore, Anne Perdrix, Florian Clat |
| ESR1 F404 mutations and acquired resistance to fulvestrant in ESR1 mutant breast cancer. Cancer discovery 2023 11 . Belinda Kingston, Alex Pearson, Maria Teresa Herrera-Abreu, Li-Xuan Sim, Rosalind J Cutts, Heena Shah, Laura Moretti, Lucy S Kilburn, Hannah Johnson, Iain R Macpherson, Alistair Ring, Judith M Bliss, Yingwei Hou, Weiyi Toy, John A Katzenellenbogen, Sarat Chandarlapaty, Nicholas C Turn |
| Changes in cell-free DNA after short-term palbociclib and fulvestrant treatment for advanced or metastatic hormone receptor-positive and human epidermal growth factor 2-negative breast cancer. Breast cancer research and treatment 2023 10 . Takayuki Iwamoto, Naoki Niikura, Kenichi Watanabe, Takashi Takeshita, Yuichiro Kikawa, Kokoro Kobayashi, Nobutaka Iwakuma, Takuho Okamura, Hiroshi Tada, Shinji Ozaki, Toshitaka Okuno, Uhi Toh, Yutaka Yamamoto, Michiko Tsuneizumi, Hiroshi Ishiguro, Norikazu Masuda, Shigehira Sa |
| ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC). PLoS genetics 2023 1 19 (1): e1010563. Ferrando Lorenzo, Vingiani Andrea, Garuti Anna, Vernieri Claudio, Belfiore Antonino, Agnelli Luca, Dagrada Gianpaolo, Ivanoiu Diana, Bonizzi Giuseppina, Munzone Elisabetta, Lippolis Luana, Dameri Martina, Ravera Francesco, Colleoni Marco, Viale Giuseppe, Magnani Luca, Ballestrero Alberto, Zoppoli Gabriele, Pruneri Giancar |
| Estrogen receptor alpha (ESR1) gene polymorphism (rs2234693 and rs2046210) with breast cancer risk in pashtun population of Khyber Pakhtunkhwa. Molecular biology reports 2023 1 50 (3): 2445-2451. Shahzad Savera, Khan Najeeb Ullah, Sombal Wafa, Shah Rizwan Ullah, Khan Aakif Ullah, Iqbal Aqib, Munir Iqb |
| Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry. Genome medicine 2023 1 15 (1): 7. Mueller Stefanie H, Lai Alvina G, Valkovskaya Maria, Michailidou Kyriaki, Bolla Manjeet K, Wang Qin, Dennis Joe, Lush Michael, Abu-Ful Zomoruda, Ahearn Thomas U, Andrulis Irene L, Anton-Culver Hoda, Antonenkova Natalia N, Arndt Volker, Aronson Kristan J, Augustinsson Annelie, Baert Thais, Freeman Laura E Beane, Beckmann Matthias W, Behrens Sabine, Benitez Javier, Bermisheva Marina, Blomqvist Carl, Bogdanova Natalia V, Bojesen Stig E, Bonanni Bernardo, Brenner Hermann, Brucker Sara Y, Buys Saundra S, Castelao Jose E, Chan Tsun L, Chang-Claude Jenny, Chanock Stephen J, Choi Ji-Yeob, Chung Wendy K, , Colonna Sarah V, , Cornelissen Sten, Couch Fergus J, Czene Kamila, Daly Mary B, Devilee Peter, Dörk Thilo, Dossus Laure, Dwek Miriam, Eccles Diana M, Ekici Arif B, Eliassen A Heather, Engel Christoph, Evans D Gareth, Fasching Peter A, Fletcher Olivia, Flyger Henrik, Gago-Dominguez Manuela, Gao Yu-Tang, García-Closas Montserrat, García-Sáenz José A, Genkinger Jeanine, Gentry-Maharaj Aleksandra, Grassmann Felix, Guénel Pascal, Gündert Melanie, Haeberle Lothar, Hahnen Eric, Haiman Christopher A, Håkansson Niclas, Hall Per, Harkness Elaine F, Harrington Patricia A, Hartikainen Jaana M, Hartman Mikael, Hein Alexander, Ho Weang-Kee, Hooning Maartje J, Hoppe Reiner, Hopper John L, Houlston Richard S, Howell Anthony, Hunter David J, Huo Dezheng, , Ito Hidemi, Iwasaki Motoki, Jakubowska Anna, Janni Wolfgang, John Esther M, Jones Michael E, Jung Audrey, Kaaks Rudolf, Kang Daehee, Khusnutdinova Elza K, Kim Sung-Won, Kitahara Cari M, Koutros Stella, Kraft Peter, Kristensen Vessela N, Kubelka-Sabit Katerina, Kurian Allison W, Kwong Ava, Lacey James V, Lambrechts Diether, Le Marchand Loic, Li Jingmei, Linet Martha, Lo Wing-Yee, Long Jirong, Lophatananon Artitaya, Mannermaa Arto, Manoochehri Mehdi, Margolin Sara, Matsuo Keitaro, Mavroudis Dimitrios, Menon Usha, Muir Kenneth, Murphy Rachel A, Nevanlinna Heli, Newman William G, Niederacher Dieter, O'Brien Katie M, Obi Nadia, Offit Kenneth, Olopade Olufunmilayo I, Olshan Andrew F, Olsson Håkan, Park Sue K, Patel Alpa V, Patel Achal, Perou Charles M, Peto Julian, Pharoah Paul D P, Plaseska-Karanfilska Dijana, Presneau Nadege, Rack Brigitte, Radice Paolo, Ramachandran Dhanya, Rashid Muhammad U, Rennert Gad, Romero Atocha, Ruddy Kathryn J, Ruebner Matthias, Saloustros Emmanouil, Sandler Dale P, Sawyer Elinor J, Schmidt Marjanka K, Schmutzler Rita K, Schneider Michael O, Scott Christopher, Shah Mitul, Sharma Priyanka, Shen Chen-Yang, Shu Xiao-Ou, Simard Jacques, Surowy Harald, Tamimi Rulla M, Tapper William J, Taylor Jack A, Teo Soo Hwang, Teras Lauren R, Toland Amanda E, Tollenaar Rob A E M, Torres Diana, Torres-Mejía Gabriela, Troester Melissa A, Truong Thérèse, Vachon Celine M, Vijai Joseph, Weinberg Clarice R, Wendt Camilla, Winqvist Robert, Wolk Alicja, Wu Anna H, Yamaji Taiki, Yang Xiaohong R, Yu Jyh-Cherng, Zheng Wei, Ziogas Argyrios, Ziv Elad, Dunning Alison M, Easton Douglas F, Hemingway Harry, Hamann Ute, Kuchenbaecker Karoline |
| Genomic complexity predicts resistance to endocrine therapy and CDK4/6 inhibition in hormone receptor-positive (HR+)/HER2-negative metastatic breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 1 . Davis Andrew A, Luo Jingqin, Zheng Tiantian, Dai Chao, Dong Xiaoxi, Tan Lu, Suresh Rama, Ademuyiwa Foluso O, Rigden Caron, Rearden Timothy P, Clifton Katherine, Weilbaecher Katherine, Frith Ashley, Tandra Pavankumar K, Summa Tracy, Haas Brittney, Thomas Shana, Hernandez-Aya Leonel F, Peterson Lindsay L, Wang Xiaohong, Luo Shujun J, Zhou Kemin, Du Pan, Jia Shidong, King Bonnie L, Krishnamurthy Jairam, Ma Cynthia |
- Page last reviewed:Oct 1, 2023
- Page last updated:Nov 28, 2023
- Content source: